Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Gross Margin

The Gross Margin of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 72.07 %. In the previous year, Gross Margin was 52.43 % — a change of 37.44% (higher).

Gross Margin

72.07 %

YoY

37.44%

Last updated:

Gross Margin of Jinyu Bio-Technology Co is 2025 72.07 % . Gross Margin of Jinyu Bio-Technology Co was 2024 52.43 % . It decreases by 37.44% higher compared to the previous year.

For Jinyu Bio-Technology Co, the gross margin of 72.1% is up versus 61.2% a few years ago.

The Jinyu Bio-Technology Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
70.79 CNY
Jan 1, 2019
58.73 CNY
Jan 1, 2020
60.70 CNY
Jan 1, 2021
61.22 CNY
Jan 1, 2022
54.39 CNY
Jan 1, 2023
58.20 CNY
Jan 1, 2024
52.43 CNY
Jan 1, 2025
72.07 CNY
The Jinyu Bio-Technology Co Gross Margin history
YEARGross MarginYoY
72.07 %+37.44%
52.43 %-9.90%
58.20 %+7.01%
54.39 %-11.17%
61.22 %+0.86%
60.70 %+3.36%
58.73 %-17.03%
70.79 %-10.51%
79.10 %+2.17%
77.42 %+2.56%
75.49 %-0.14%
75.59 %+10,701.30%
0.70 %+3.90%
0.67 %-1.87%
0.69 %+44.36%
0.48 %+16.11%
0.41 %+2.58%
0.40 %-12.59%
0.46 %+8.77%
0.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Gross Margin of Jinyu Bio-Technology Co is 72.07 % in 2025.

Gross Margin of Jinyu Bio-Technology Co changed from 52.43 % to 72.07 %, representing a 37.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Jinyu Bio-Technology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Jinyu Bio-Technology Co